Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v15-FR | Version v12-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2021-12-13 | 2021-09-28 |
| Drug Identification Number | 02446901 | 02446901 |
| Brand name | ZERBAXA | ZERBAXA |
| Common or Proper name | ceftolozane & tazobactam Powder for injection | ceftolozane & tazobactam Powder for injection |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | CEFTOLOZANE TAZOBACTAM | CEFTOLOZANE TAZOBACTAM |
| Strength(s) | 1G 0.5G | 1G 0.5G |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | ZERBAXA 1G/0.5G 10 VIAL | ZERBAXA 1G/0.5G 10 VIAL |
| ATC code | J01DI | J01DI |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | ||
| Actual start date | 2020-12-07 | 2020-12-07 |
| Estimated end date | 2021-12-17 | 2021-12-17 |
| Actual end date | 2021-12-10 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |